Overview

Gender

male

Samir Patel joined Alterna Capital Partners as Principal in 2014. Samir Patel is the Co-founder and President of Ophthotech Corporation. He also serves as Vice Chairman on its Board of Directors. Previously, Dr. Patel was the co-founder of Eyetech Pharmaceuticals where he was the Chief Medical Officer, and served on its Board of Directors.

Prior to joining Ophthotech, Dr. Patel spent over a decade in academic medicine. He joined the University of Chicago, Department of Ophthalmology and Visual Science in 1991 where he served as the Director of the Retina Service and the residency program and was an Associate Professor of Ophthalmology. His area of academic interest focused on cell based therapies for Age Related Macular Degeneration and while at the University of Chicago, he was amongst the first to perform human retinal transplant in the world.

Dr. Patel received his Medical Degree from the University of Massachusetts Medical School and ophthalmology training from the University of Chicago. He received his training in retinal surgery from the Massachusetts Eye and Ear Infirmary at the Harvard Medical School.

Dr. Patel has been a consultant to a number of ophthalmic biotechnology companies, and a consultant to multiple healthcare venture firms. He has served on the scientific advisory board of Aerie Pharmaceuticals. Dr. Patel has also served as a director of Eyetech, EyeGate Pharma and Mimetogen. Currently, in addition to Ophthotech, he serves on the board of directors of AFER-ARVO.